Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors

NCT05874063 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

387

Enrollment

OTHER

Sponsor class

Conditions

Germ Cell Tumor

Interventions

DRUG: Thromboprophylaxis

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris